carbostyril has been researched along with Tachycardia, Ventricular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolker, M; Fabbri, LM; Horton, R; Martin, C; Overend, T; Van de Maele, B | 1 |
| Galindo-Tovar, A; Kaumann, AJ | 1 |
| Abe, H; Awaji, T; Hashimoto, K; Motomura, S; Wu, Z | 1 |
1 trial(s) available for carbostyril and Tachycardia, Ventricular
| Article | Year |
|---|---|
Cardiovascular safety of QVA149, a combination of Indacaterol and NVA237, in COPD patients.
Topics: Administration, Inhalation; Aged; Atrial Fibrillation; Blood Pressure; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electrocardiography, Ambulatory; Female; Glycopyrrolate; Heart Rate; Humans; Hyperkalemia; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Tachycardia, Ventricular | 2010 |
2 other study(ies) available for carbostyril and Tachycardia, Ventricular
| Article | Year |
|---|---|
Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Female; Heart Atria; Heart Rate; Heart Ventricles; Imidazoles; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Propanolamines; Quinolones; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Rolipram; Sinoatrial Node; Tachycardia, Sinus; Tachycardia, Ventricular | 2008 |
Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Disease Models, Animal; Dogs; Epinephrine; Female; Heart Rate; Male; Myocardial Contraction; Myocardial Ischemia; Ouabain; Quinolones; Tachycardia, Ventricular; Vasodilation; Ventricular Fibrillation | 1993 |